HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karim Gaber Selected Research

3- acetoxy- 1,11,12- dolabell- 4,8,18- trien- 16- al (ADTA)

4/2022Updates in the Surgical Management of Recurrent Clubfoot Deformity: a Scoping Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karim Gaber Research Topics

Disease

1Postoperative Pain
01/2024
1Scoliosis
01/2024
1Respiratory Insufficiency (Respiratory Failure)
01/2024
1Foot Deformities (Foot Deformity)
01/2023
1Pain (Aches)
10/2022
1Necrosis
04/2022
1Equinus Deformity
04/2022

Drug/Important Bio-Agent (IBA)

1Morphine (MS Contin)FDA LinkGeneric
01/2024
13- acetoxy- 1,11,12- dolabell- 4,8,18- trien- 16- al (ADTA)IBA
04/2022

Therapy/Procedure

1Postoperative Care
01/2024
1Spinal Fusion (Spondylosyndesis)
01/2024
1Foot Orthoses
01/2023
1Operative Surgical Procedures
01/2023
1Physical Therapy Modalities (Physical Therapy Technique)
01/2023
1Reoperation
10/2022
1Osteotomy
04/2022